REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Biolink OOO (Russia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Biolink OOO Profile Updated: August 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Biolink OOO is an enterprise located in Russia, with the main office in Novosibirsk. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. The company was established on October 04, 2002. The company’s latest financial report indicates a net sales revenue drop of 9.42% in 2023. Its’ total assets recorded a growth of 2.6%. In 2023, Biolink OOO’s net profit margin decreased by 15.88%.

Headquarters
Nikolaeva, 13, 205
Novosibirsk; Novosibirsk Oblast; Postal Code: 630090

Contact Details: Purchase the Biolink OOO report to view the information.

Website: http://mcstatus.ru

Basic Information
Outstanding Shares:
Purchase the Biolink OOO report to view the information.
Registered Capital:
Purchase the Biolink OOO report to view the information.
Incorporation Date:
October 04, 2002
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
10%
Purchase this report to view the information.
7.5%
Purchase this report to view the information.
7.5%
Company Performance
Financial values in the chart are available after Biolink OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-9.42%▼
Total operating revenue
-9.42%▼
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-71.97%▼
Total assets
2.6%▲
Total equity
7.23%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-15.88%▼
Return on Equity (ROE)
-19.06%▼
Quick Ratio
0.14%▲
Cash Ratio
-0.43%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo